Company Search:
Advanced Search
Sponsored Links
Raqualia Pharma Incorporated Company Snapshot
Raqualia Pharma Incorporated operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Raqualia Pharma Incorporated with three other companies in this sector in Japan: Carna Biosciences Inc (2016 sales of 811.60 million Japanese Yen [US$7.34 million] of which 88% was Drug Discovery Support Business), Human Metabolome Technologies Inc (780.38 million Japanese Yen [US$7.06 million] of which 90% was Metabolome analysis business), and BrightPath Biotherapeutics Co Ltd (822.56 million Japanese Yen [US$7.44 million] of which 100% was Commerical Physical Research).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Raqualia Pharma Incorporated were ¥705.24 million (US$6.38 million). This is an increase of 384.7% versus 2015, when the company's sales were ¥145.50 million. The sales level in 2016 was fairly close to the level five years ago: in 2011, Raqualia Pharma Incorporated had sales of ¥684.20 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Raqualia Pharma Incorporated
  Stock Performance Chart for Raqualia Pharma Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 3,050.00
(Figures in Japanese Yen)
1 Week 20.0%   13 Weeks 130.9%  
4 Weeks 189.1%   52 Weeks 633.2%  
Raqualia Pharma Incorporated Key Data:
  Ticker: 4579 Country: Japan
  Exchanges: TYO JSQ Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 705,235,000
(Year Ending Jan 2017).
Employees: 50
  Currency: Japanese Yen Market Cap: 58,728,317,300
  Fiscal Yr Ends: December Shares Outstanding: 19,255,186
  Share Type: Ordinary Closely Held Shares: 3,716,800
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.